Results 161 to 170 of about 23,471 (208)

Synthesis of novel SRPK1-targeting hybrid compounds incorporating antimetabolites for cancer therapy. [PDF]

open access: yesRSC Med Chem
Leonidis G   +6 more
europepmc   +1 more source

Antimetabolites

Current Opinion in Oncology, 1992
Research efforts over the past year further elucidate the determinants of sensitivity and mechanisms of resistance to the antimetabolites fluorouracil, methotrexate, and cytarabine. Progress has been made in clarifying the complex regulation of target enzyme expression for these antimetabolites.
A P, Chen, J L, Grem
openaire   +4 more sources

Antimetabolite Radiosensitizers

Journal of Clinical Oncology, 2007
Radiosensitization with antimetabolites has improved clinical outcome for patients with solid malignancies, especially cancers of the GI tract, cervix, and head and neck. Fluorouracil (FU) and hydroxyurea have been widely used clinically during the last four decades, and promising results have been observed more recently with gemcitabine. Although the
Donna S, Shewach, Theodore S, Lawrence
openaire   +2 more sources

Antimetabolites.

Cancer chemotherapy and biological response modifiers, 1990
The mechanisms of action of MTX and 5-FU have been further elucidated. Such studies will be important for the design of drug combinations and for the development of novel antifolate and fluoropyrimidine analogs. A greater understanding of MTX and ara-C transport and drug levels required to optimize transport may also aid in these endeavors ...
C J, Allegra   +5 more
openaire   +3 more sources

Antimetabolites

Baillière's Clinical Haematology, 1991
R L, Capizzi, J C, White, D J, Fernandes
openaire   +4 more sources

Topical Antimetabolites

Annual Review of Medicine, 1970
H S, Zackheim, E M, Farber
openaire   +2 more sources

Antimetabolites

2007
Kenneth W. Wyman   +2 more
  +5 more sources

Home - About - Disclaimer - Privacy